Working… Menu
Trial record 26 of 245 for:    Recruiting, Not yet recruiting, Available Studies | Headache

Study on Indomethacin-responsive Headaches

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03967483
Recruitment Status : Not yet recruiting
First Posted : May 30, 2019
Last Update Posted : May 30, 2019
Information provided by (Responsible Party):
Anne Ducros, French Society for the Study of Migraine Headache

Brief Summary:
Description of modalities concerning the patient care of headaches sensible to indometacine.

Condition or disease Intervention/treatment
Headache, Migraine Drug: Indometacin

Detailed Description:
Description of clinical profile, treatment of crisis and background treatment

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Non Interventional Study on Indomethacin-responsive Headaches
Estimated Study Start Date : June 1, 2019
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : June 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Headache

Intervention Details:
  • Drug: Indometacin
    patient who are taken indomatacin for headaches and migraine

Primary Outcome Measures :
  1. Description of headaches sensible to indometacine [ Time Frame: 24 monthes ]
    Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient sufffuring from headaches or migraine and who is receiving Indometacine

Inclusion Criteria:

  • patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches
  • patient who are taking indometacine
  • patient with written consent form

Exclusion Criteria:

  • patient under 18 years
  • pregnant woman or breastfeeding patient
  • patient who refuses to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03967483

Layout table for location contacts
Contact: Anne DONNET 0491384340

Sponsors and Collaborators
Anne Ducros

Layout table for additonal information
Responsible Party: Anne Ducros, Pr, French Society for the Study of Migraine Headache Identifier: NCT03967483     History of Changes
Other Study ID Numbers: 2019-A00406-51
First Posted: May 30, 2019    Key Record Dates
Last Update Posted: May 30, 2019
Last Verified: May 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Headache Disorders, Primary
Headache Disorders
Migraine Disorders
Neurologic Manifestations
Signs and Symptoms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Gout Suppressants
Tocolytic Agents
Reproductive Control Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action